Where does Varian Medical Systems Particle Therapy GMBH & Co. KG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Varian Medical Systems Particle Therapy GMBH & Co. KG ranks #5,486 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Varian Medical Systems Particle Therapy GMBH & Co. KG hold?

Varian Medical Systems Particle Therapy GMBH & Co. KG holds 63 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Varian Medical Systems Particle Therapy GMBH & Co. KG's Innovation Score?

Varian Medical Systems Particle Therapy GMBH & Co. KG has an Innovation Score of 42.1 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Varian Medical Systems Particle Therapy GMBH & Co. KG focus on?

Varian Medical Systems Particle Therapy GMBH & Co. KG's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 58 patents, ranking #62 of 1,943 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Varian Medical Systems Particle Therapy GMBH & Co. KG's patent grant rate increasing or decreasing?

Varian Medical Systems Particle Therapy GMBH & Co. KG's recent grant velocity is +48% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Varian Medical Systems Particle Therapy GMBH & Co. KG's patents?

Varian Medical Systems Particle Therapy GMBH & Co. KG's patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Varian Medical Systems Particle Therapy GMBH & Co. KG

Q: How is the Varian Medical Systems Particle Therapy GMBH & Co. KG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 63 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Varian ranks #5,486 of 49,997 tracked US assignees by granted-patent volume, with 63 patents across 10 technology areas.

#5,486
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.1/100): 19.6
avg claims per patent: +48%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5486 · Foreign Corporation #5,486 · 63 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 63 grants
UPPER-Q #5,486/49,997
PHOTO-FINISH Ultravision
CPC-FOCUS A61N · 10 areas
INNOV-PAR 42.1/100
CLAIMS-RICH 19.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +48% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ultravision Technologies, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Varian’s 42.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.4 pts (34%) Velocity 4.8 pts (11%) Breadth 11.2 pts (27%) Claim depth 11.8 pts (28%)

Qualcomm Incorporated · highest

85
Comscore · near

42
Nisca · near

42
Rockwell Automation… · near

42
Varian Medical… · this assignee

42
Zhejiang Shenghui… · near

42
3D Lighting… · lowest

7

What this shows Varian's Innovation Score is 42.1/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Varian?

Each dot is one of Varian’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Varian’s own 19.6 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Varian vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Varian's grants concentrate

Varian Medical Systems Particle Therapy GMBH & Co. KG is a focused PatentsView assignee: 10 CPC subclasses with 92.1% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (10 grants) versus a trough of 2 in 2016. By volume, Varian sits between University Industry Foundation, Yonsei University and Welltec Oilfield Solutions AG.

Varian's three-year grant acceleration

From 2019–2021 to 2022–2024, Varian Medical Systems Particle Therapy GMBH & Co. KG moved from 25 to 18 grants (0.72x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

University Indust…

63
Unlikely Artifici…

63
UWM Research Foun…

63
Ultravision

63
Valeo Japan

63
Virtual Hold Tech…

63
Vitesco USA

63
Welltec Oilfield…

63
Varian Medical Sy… ◀

63

What this shows Varian holds 63 patents at rank #5,485, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Varian

By rank, the assignees closest to #5,485 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Varian's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Varian, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Varian ranks #62 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Rockwell Automation Asia Pacific Business Center Pte. Ltd. 42 Zhejiang Shenghui Lighting Co., Ltd. 42 Nisca Corporation 42 Comscore, Inc. 42

Similar claim depth

Nearest assignees by average claims per patent (19.6 here).

Infinidat Ltd. 19.6 avg Procore Technologies, Inc. 19.6 avg PIXAR 19.6 avg DisplayLink (UK) Limited 19.6 avg

Varian's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Varian Medical Systems Particle Therapy GMBH & Co. KG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	4.8%
2016	2	3.2%
2017	7	11.1%
2018	2	3.2%
2019	9	14.3%
2020	10	15.9%
2021	6	9.5%
2022	4	6.3%
2023	6	9.5%
2024	8	12.7%
2025partial year	6	9.5%

Which technologies does Varian Medical Systems Particle Therapy GMBH & Co. KG patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 58

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 16

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 11

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 7

G01T - Measurement OF Nuclear OR X-radiation 7

H01J - Electric Discharge Tubes OR Discharge Lamps 6

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 3

G06T - Image Data Processing OR Generation, IN General 2

A61B - DIAGNOSIS; SURGERY; Identification 2

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 2

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Varian Medical Systems Particle Therapy GMBH & Co. KG's patent record in context - here's where to go next.

Varian Medical Systems Particle Therapy GMBH & Co. KG's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 92.1% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #5,486 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Varian Medical Systems Particle Therapy GMBH & Co. KG against University Industry Foundation, Yonsei University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.